Cel-Sci Corporation (CVM) Live Share Price, Invest From India

Cel-Sci Corporation Stock Performance

as on July 17, 2026 at 2:16 pm IST

Day's Low
Day's High
$1.10
Day's Price Range
$1.43
$1.15
4.35%
Downside
24.35%
Upside
52 Week's Low
52 Week's High
$0.89
52-Week Price Range
$13.48
$1.15
22.61%
Downside
1071.90%
Upside

Cel-Sci Corporation share price movements today

Previous Close: $1.15
Open: $1.18
Volume: 5.8M
Day's Low - High: $1.10 - $1.43
52 Week Low - High: $0.89 - $13.48

Cel-Sci Corporation Historical Returns

1 Month Return: + 4.55 %
3 Month Return: -76.77 %
1 Year Return: -72.42 %
3 Year Return: -98.66 %
5 Year Return: -99.52 %

Cel-Sci Corporation Stock Fundamentals & Key Indicators

Check Cel-Sci Corporation market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$20.1M

EPS (TTM)

-4.16

Dividend Yield

0.00%

Quarterly Earnings Growth YOY

0.00%

PE Ratio (TTM)

PEG Ratio

1.1158

EBITDA

-20.2M

Revenue (TTM)

28.6K

Profit Margin

0.00%

Return On Equity TTM

-305.27%

Cel-Sci Corporation vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Cel-Sci Corporation with its industry peers.

Company	Analyst View	Market Cap	5 Years Return %	PE Ratio	Profit Margin %	Dividend Yield %
Cel-Sci Corporation	BUY	$20.1M	-99.52%	NA	0.00%	NA
Revolution Medicines Inc.	BUY	$39.2B	501.07%	NA	0.00%	NA
Vertex Pharmaceuticals Inc.	BUY	$122.9B	140.28%	28.76	35.51%	NA
Regeneron Pharmaceuticals Inc.	BUY	$71.2B	16.41%	16.59	29.65%	0.54%

Stock Returns calculator for Cel-Sci Corporation Stock including INR - Dollar returns

The Cel-Sci Corporation stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Impact: The bonus return you make when the US Dollar rises against the Rupee; calculated on the full amount you walk away with, not just what you invested in.

Investment Value

₹1,00,000

Cel-Sci Corporation investment value today

Current value as on today

₹30,933

Returns

-₹69,067

(-69.07%)

Returns from Cel-Sci Corporation Stock

-₹72,422 (-72.42%)

Dollar Impact

₹3,356 (+3.36%)

Analyst Recommendation on Cel-Sci Corporation Stock

Based on 5 analysts

BUY

80.00%

Buy

20.00%

Hold

0.00%

Sell

Based on 5 analysts, 80% of analysts recommend a 'BUY' rating for Cel-Sci Corporation. Average target price of $25

Cel-Sci Corporation Share Price Target

Get share price movements and forecasts by analysts on Cel-Sci Corporation.

What analysts predicted

95.4%UPSIDE

Target Price

$25

Current Price

$1.15

Analyzed by

5 Analysts

Target

$25.00

Cel-Sci Corporation target price $25, a slight upside of 95.4% compared to current price of $1.15. According to 5 analysts rating.

Indian Investors' Interest in Cel-Sci Corporation Stock

Search interest for Cel-Sci Corporation Stock has increased by 28% in the last 30 days, reflecting an upward trend in search activity.

Time period: June 17, 2026 to July 17, 2026

Change:28% versus previous 30 day period

Cel-Sci Corporation Quarterly Profit & Loss

All numbers in Millions USD

	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026
Total Revenue	-	-	-	-	5	-	-	-	-	-
Gross Profit	-1	0	0	-	0	-4	0	0	-3	0
Operating Income	-6	-7	-6	-6	-6	-6	-5	-6	-5	-5
EBITDA	-5	-6	-5	-	-5	-5	-4	-5	-4	-4
Interest Expense	0	0	0	0	0	0	0	0	0	0
Depreciation	1	0	0	0	0	0	0	0	0	0
Income Before Tax	-6	-7	-6	-6	-7	-6	-5	-6	-5	-5
Income Tax Expense	0	0	0	-	0	-	-	-	-	-
Net Income	-6	-7	-6	-6	-7	-6	-5	-6	-5	-5
Net Profit Margin	0.00%	0.00%	0.00%	0.00%	-118.81%	0.00%	0.00%	0.00%	0.00%	0.00%

Cel-Sci Corporation Annual Profit & Loss

All numbers in Millions USD

	Sep 2016	Sep 2017	Sep 2018	Sep 2019	Sep 2020	Sep 2021	Sep 2022	Sep 2023	Sep 2024	Sep 2025
Total Revenue	0	0	0	0	0	-	-	-	-	-
Gross Profit	0	0	0	0	0	0	-3	-3	-3	-15
Operating Income	-25	-21	-16	-20	-28	-36	-36	-31	-26	-24
EBITDA	-9	-9	-16	-19	-27	-34	-31	-27	-22	-20
Interest Expense	-	4	-	1	1	1	1	0	0	0
Depreciation	-	0	0	0	2	2	3	3	3	3
Income Before Tax	-11	-14	-31	-22	-30	-36	-36	-32	-26	-25
Income Tax Expense	-14	-6	-15	2	1	2	1	0	-	-
Net Income	-11	-14	-31	-24	-32	-39	-38	-32	-26	-25
Net Profit Margin	-4022.56%	-20810.33%	-6680.68%	-5336.04%	-5767.93%	0.00%	0.00%	0.00%	0.00%	0.00%

Cel-Sci Corporation Quarterly Cash Flow

All numbers in Millions USD

	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026
Net Income	-7	-6	-26	-7	-6	-5	-6	-5	-5
Operating Cash Flow	-4	-4	-18	-4	-4	-3	-4	-4	-4
Investing Cash Flow	-	0	0	0	0	0	0	-	-
Financing Cash Flow	6	0	19	4	1	3	13	0	0
Change in Cash	2	-4	0	0	-2	0	9	-4	-4

Cel-Sci Corporation Annual Cash Flow

All numbers in Millions USD

	Sep 2017	Sep 2018	Sep 2019	Sep 2020	Sep 2021	Sep 2022	Sep 2023	Sep 2024	Sep 2025
Net Income	-14	-31	-22	-30	-36	-36	-32	-26	-25,411
Operating Cash Flow	-13	-13	-16	-15	-18	-18	-22	-18	-17,119
Investing Cash Flow	0	0	0	-2	-15	5	0	0	-38
Financing Cash Flow	13	21	14	25	54	0	4	19	23,373
Change in Cash	0	7	-1	7	20	-13	-18	0	6,215

Insights on Cel-Sci Corporation

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

NO EFFECT
Against Peers
In the last 1 year, Revolution Medicines, Inc. Common Stock has given 358.8% return, outperforming this stock by 431.2%
NO EFFECT
Against Peers
In the last 3 years, Revolution Medicines, Inc. Common Stock has given 573.4% return, outperforming this stock by 672.1%
NEGATIVE IMPACT
Price Dip
In the last 7 days, CVM stock has moved down by -16.7%

About Cel-Sci Corporation

CEL-SCI Corporation, a clinical-stage biotechnology company, engages in the research and development to treat cancer and other diseases by using the immune system in the United States. The company's lead immunotherapy is Multikine, which has completed Phase III clinical trials for the potential treatment of certain head and neck cancers. It is also developing Ligand Epitope Antigen Presentation System (LEAPS) technology, a patented T-cell modulation process that stimulates the human immune system to fight bacterial, viral, parasitic infections, autoimmune conditions, allergies, transplantation rejections, and cancer, as well as to potentially treat rheumatoid arthritis. In addition, the company's LEAP product candidates include CEL-2000; CEL-4000; and CEL-5000 that are in preclinical trials for potential rheumatoid arthritis therapeutic treatments. CEL-SCI Corporation has a strategic partnership with Saudi Arabian Pharma Company for Multikine in the treatment of head and neck cancer. The company was incorporated in 1983 and is headquartered in Vienna, Virginia.

Organisation	Cel-Sci Corporation
Headquarters	8229 Boone Boulevard, Vienna, VA, United States, 22182
Industry	Biotechnology
CEO	Mr. Geert R. Kersten Esq.
E-voting on shares	Click here to vote

Key Management of Cel-Sci Corporation

Name	Title
Dr. Eyal Talor Ph.D.	Chief Scientific Officer
Mr. John Cipriano	Senior Vice President of Regulatory Affairs
Mr. Geert R. Kersten Esq.	CEO, CAO,Treasurer and Director
Ms. Patricia B. Prichep	Chief Financial & Operations Officer, Compliance Officer & Corporate Secretary

FAQs

What is Cel-Sci Corporation share price today?

Cel-Sci Corporation share price today is $1.15 as on July 17, 2026 at 8:46 am IST at the close of the market. Cel-Sci Corporation share today touched a day high of $1.43 and a low of $1.10.

What is the 52 week high and 52 week low for Cel-Sci Corporation share?

Cel-Sci Corporation share touched a 52 week high of $13.48 on August 27, 2025 and a 52 week low of $0.89 on May 12, 2026. Cel-Sci Corporation stock price today i.e. July 17, 2026 at 8:46 am IST is closed at $1.15,which is 91.47% down from its 52 week high and 29.21% up from its 52 week low.

What is Cel-Sci Corporation's market capitalisation today?

Cel-Sci Corporation market capitalisation is $0.00T as on July 17, 2026 at 8:46 am IST.

How to invest in Cel-Sci Corporation Stock (CVM) from India?

Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
Step 2: Search for Cel-Sci Corporation on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Cel-Sci Corporation Shares that will get you 1.3043 shares as per Cel-Sci Corporation share price of $1.15 per share as on July 17, 2026 at 8:46 am IST.

What is the minimum amount required to buy Cel-Sci Corporation Stock (CVM) from India?

Indian investors can start investing in Cel-Sci Corporation (CVM) shares with as little as ₹96.335 or $1 (as of July 17, 2026 at 4:36 pm IST) using the INDmoney app.
For example: If you want to invest $10 or ₹963.35 in Cel-Sci Corporation stock (as per the Rupee-Dollar exchange rate as on July 17, 2026 at 4:36 pm IST). Based on Cel-Sci Corporation share’s latest price of $1.15 as on July 17, 2026 at 8:46 am IST, you will get 8.6957 shares of Cel-Sci Corporation. Learn more about fractional shares .

What are the returns that Cel-Sci Corporation has given to Indian investors in the last 5 years?

Cel-Sci Corporation stock has given -99.52% share price returns and 28.17% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?